US Stock MarketDetailed Quotes

KROS Keros Therapeutics

Watchlist
  • 45.540
  • -0.500-1.09%
Close Aug 16 16:00 ET
  • 45.560
  • +0.020+0.04%
Post 16:34 ET
1.71BMarket Cap-8877P/E (TTM)

Keros Therapeutics Key Stats

Keros Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 5.125M--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q183.000K / 0.000--
--2023/Q4143.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 5.125M--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q183.000K / 0.000--
--2023/Q4143.000K / 0.000--

Unlock Free Earnings Estimates

Keros Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Aug 8, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg